| |
| |
|
| Insider
Information: |
Adda Nathalie |
| Relationship: |
Sr. VP & Chief Medical... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
34,982 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$456,865 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
34,982 |
|
|
| Total
Value |
$456,865 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enanta Pharmaceuticals Inc |
ENTA |
Sr. VP & Chief Medical... |
2022-04-04 |
34,982 |
2017-02-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-09-20 |
4 |
AS |
$93.02 |
$396,036 |
D/D |
(4,155) |
0 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-08-20 |
4 |
AS |
$90.58 |
$383,596 |
D/D |
(4,155) |
310 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2017-02-13 |
4 |
D |
$29.82 |
$23,613 |
D/D |
(792) |
1,308 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-07-18 |
4 |
AS |
$123.72 |
$629,843 |
D/D |
(5,045) |
1,510 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2017-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
2,100 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-07-18 |
4/A |
AS |
$123.72 |
$519,736 |
D/D |
(4,155) |
2,400 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-06-18 |
4 |
AS |
$113.90 |
$477,222 |
D/D |
(4,155) |
3,600 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-09-20 |
4 |
OE |
$43.46 |
$128,424 |
D/D |
2,955 |
4,155 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-08-20 |
4 |
OE |
$43.46 |
$128,424 |
D/D |
2,955 |
4,465 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-05-16 |
4 |
AS |
$103.85 |
$437,333 |
D/D |
(4,155) |
4,800 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-04-16 |
4 |
AS |
$85.11 |
$361,560 |
D/D |
(4,225) |
6,000 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-07-18 |
4 |
OE |
$43.46 |
$128,424 |
D/D |
2,955 |
6,555 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-02-12 |
4 |
D |
$76.85 |
$197,184 |
D/D |
(2,566) |
7,270 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-06-18 |
4 |
OE |
$43.46 |
$128,424 |
D/D |
2,955 |
7,755 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-05-16 |
4 |
OE |
$43.46 |
$128,424 |
D/D |
2,955 |
8,955 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,528 |
9,836 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2018-04-16 |
4 |
OE |
$43.46 |
$128,424 |
D/D |
2,955 |
10,225 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2019-02-12 |
4 |
D |
$88.88 |
$476,041 |
D/D |
(5,356) |
10,394 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2019-12-16 |
4 |
D |
$63.88 |
$148,904 |
D/D |
(2,331) |
13,313 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2020-02-12 |
4 |
D |
$52.76 |
$57,561 |
D/D |
(1,091) |
15,634 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2019-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
15,644 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
15,750 |
15,750 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2020-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,412 |
16,725 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2020-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,600 |
23,234 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & Chief Medical Officer |
• – – |
2020-12-15 |
4 |
D |
$42.52 |
$65,481 |
D/D |
(1,540) |
26,944 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
